Cargando…

(416) Heart Transplantation with Covid 19 Positive Donor Hearts

PURPOSE: Coronavirus disease 2019 (COVID-19) causes a profound systemic inflammatory response and the transmissibility was unknown early in the pandemic; consequently, transplant centers were hesitant to utilize organs from COVID-19+ donors. This study aims to analyze short and medium-term outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolfe, S.B., Singh, R., Paneitz, D.C., Asija, R., Rabi, S., Michel, E., D'Alessandro, D., Ganapathi, A., Osho, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068084/
http://dx.doi.org/10.1016/j.healun.2023.02.431
_version_ 1785018612688355328
author Wolfe, S.B.
Singh, R.
Paneitz, D.C.
Asija, R.
Rabi, S.
Michel, E.
D'Alessandro, D.
Ganapathi, A.
Osho, A.
author_facet Wolfe, S.B.
Singh, R.
Paneitz, D.C.
Asija, R.
Rabi, S.
Michel, E.
D'Alessandro, D.
Ganapathi, A.
Osho, A.
author_sort Wolfe, S.B.
collection PubMed
description PURPOSE: Coronavirus disease 2019 (COVID-19) causes a profound systemic inflammatory response and the transmissibility was unknown early in the pandemic; consequently, transplant centers were hesitant to utilize organs from COVID-19+ donors. This study aims to analyze short and medium-term outcomes in recipients of hearts from COVID-19+ donors. METHODS: The Organ Procurement and Transplantation Network database was queried for all heart transplant recipients between January 1, 2020 and December 31, 2021. Recipients of COVID-19+ donor hearts were compared to recipients of COVID-19- donor hearts. Pediatric recipients, multiorgan transplants, donors without COVID-19 testing, and recipients allocated under the old heart allocation system were excluded. One to three propensity score matching was used to match COVID+ donor heart recipients to COVID- donor heart recipients. RESULTS: Over the study period, 4,621 heart transplant recipients met inclusion-exclusion criteria, including 62 recipients of COVID+ donor hearts. After matching on pre-transplant recipient and donor characteristics, the 59 COVID+ donor heart recipients were matched to 177 COVID- donor heart recipients. Baseline characteristics were similar following matching. Thirty-day survival was similar between groups (COVID- 95.5% vs. COVID+ 100.0%, log rank p=0.10) as was six-month survival (COVID- 93.2% vs. COVID+ 98.3%, log rank p=0.15; Figure 1). National COVID+ donor heart usage varied by region, with region 11 transplanting the largest proportion of COVID+ hearts [11/62 (17.7%)] and region 10 transplanting the least [1/62 (1.64%)]. COVID+ heart utilization per region was greatest in region 1 [7/249 (2.8%)] and least in region 10 [1/384 (0.26%)]. CONCLUSION: Thirty-day and six-month survival in recipients of COVID+ donor hearts is similar to that of COVID- donor hearts. These data should encourage increased utilization of COVID+ donor hearts. Further analyses are needed to determine if long-term outcomes are equivalent between groups.
format Online
Article
Text
id pubmed-10068084
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-100680842023-04-03 (416) Heart Transplantation with Covid 19 Positive Donor Hearts Wolfe, S.B. Singh, R. Paneitz, D.C. Asija, R. Rabi, S. Michel, E. D'Alessandro, D. Ganapathi, A. Osho, A. J Heart Lung Transplant Article PURPOSE: Coronavirus disease 2019 (COVID-19) causes a profound systemic inflammatory response and the transmissibility was unknown early in the pandemic; consequently, transplant centers were hesitant to utilize organs from COVID-19+ donors. This study aims to analyze short and medium-term outcomes in recipients of hearts from COVID-19+ donors. METHODS: The Organ Procurement and Transplantation Network database was queried for all heart transplant recipients between January 1, 2020 and December 31, 2021. Recipients of COVID-19+ donor hearts were compared to recipients of COVID-19- donor hearts. Pediatric recipients, multiorgan transplants, donors without COVID-19 testing, and recipients allocated under the old heart allocation system were excluded. One to three propensity score matching was used to match COVID+ donor heart recipients to COVID- donor heart recipients. RESULTS: Over the study period, 4,621 heart transplant recipients met inclusion-exclusion criteria, including 62 recipients of COVID+ donor hearts. After matching on pre-transplant recipient and donor characteristics, the 59 COVID+ donor heart recipients were matched to 177 COVID- donor heart recipients. Baseline characteristics were similar following matching. Thirty-day survival was similar between groups (COVID- 95.5% vs. COVID+ 100.0%, log rank p=0.10) as was six-month survival (COVID- 93.2% vs. COVID+ 98.3%, log rank p=0.15; Figure 1). National COVID+ donor heart usage varied by region, with region 11 transplanting the largest proportion of COVID+ hearts [11/62 (17.7%)] and region 10 transplanting the least [1/62 (1.64%)]. COVID+ heart utilization per region was greatest in region 1 [7/249 (2.8%)] and least in region 10 [1/384 (0.26%)]. CONCLUSION: Thirty-day and six-month survival in recipients of COVID+ donor hearts is similar to that of COVID- donor hearts. These data should encourage increased utilization of COVID+ donor hearts. Further analyses are needed to determine if long-term outcomes are equivalent between groups. Published by Elsevier Inc. 2023-04 2023-04-03 /pmc/articles/PMC10068084/ http://dx.doi.org/10.1016/j.healun.2023.02.431 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wolfe, S.B.
Singh, R.
Paneitz, D.C.
Asija, R.
Rabi, S.
Michel, E.
D'Alessandro, D.
Ganapathi, A.
Osho, A.
(416) Heart Transplantation with Covid 19 Positive Donor Hearts
title (416) Heart Transplantation with Covid 19 Positive Donor Hearts
title_full (416) Heart Transplantation with Covid 19 Positive Donor Hearts
title_fullStr (416) Heart Transplantation with Covid 19 Positive Donor Hearts
title_full_unstemmed (416) Heart Transplantation with Covid 19 Positive Donor Hearts
title_short (416) Heart Transplantation with Covid 19 Positive Donor Hearts
title_sort (416) heart transplantation with covid 19 positive donor hearts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068084/
http://dx.doi.org/10.1016/j.healun.2023.02.431
work_keys_str_mv AT wolfesb 416hearttransplantationwithcovid19positivedonorhearts
AT singhr 416hearttransplantationwithcovid19positivedonorhearts
AT paneitzdc 416hearttransplantationwithcovid19positivedonorhearts
AT asijar 416hearttransplantationwithcovid19positivedonorhearts
AT rabis 416hearttransplantationwithcovid19positivedonorhearts
AT michele 416hearttransplantationwithcovid19positivedonorhearts
AT dalessandrod 416hearttransplantationwithcovid19positivedonorhearts
AT ganapathia 416hearttransplantationwithcovid19positivedonorhearts
AT oshoa 416hearttransplantationwithcovid19positivedonorhearts